- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Compass Pathways Announces New Employee Grants
Biotech firm issues stock options to new hires under Nasdaq rules
Apr. 7, 2026 at 10:10pm
Got story updates? Submit your updates here. ›
Compass Pathways' new employee stock grants aim to attract top talent to the growing psychedelics industry.NYC TodayCompass Pathways, a mental health-focused biotech company, has announced the grant of stock options and restricted stock units to new employees as inducement grants under Nasdaq listing rules. The grants are part of the company's efforts to attract and retain top talent as it continues to develop its pipeline of psychedelic-based therapies.
Why it matters
Compass Pathways is a prominent player in the emerging psychedelics industry, which has seen growing investor interest and regulatory changes in recent years. The company's ability to recruit and incentivize key personnel through equity-based compensation is crucial to its long-term success.
The details
The inducement grants include the issuance of 75,000 stock options and 25,000 restricted stock units to new employees. The stock options have an exercise price equal to the closing price of Compass Pathways' American Depositary Shares on the grant date and vest over a four-year period. The restricted stock units also vest over a four-year period.
- The grants were announced on April 7, 2026.
The players
Compass Pathways
A mental health-focused biotech company that is developing psychedelic-based therapies.
Nasdaq
The stock exchange where Compass Pathways' shares are listed, which has rules allowing for inducement grants to new employees.
The takeaway
The employee inducement grants highlight Compass Pathways' efforts to build a talented team as it advances its innovative psychedelics-based treatments, which could have significant implications for the future of mental healthcare.
